NCT03126357View on ClinicalTrials.gov

CSD170401: Study to Assess Elements of Abuse Liability for Three Electronic Tobacco Vapor Products During an 11-Day In-Clinic Confinement

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 17, 2017

Primary Completion Date

May 25, 2017

Study Completion Date

May 25, 2017

Conditions
Smoking
Interventions
OTHER

Product A

Usual Brand Cigarette

OTHER

Product B

FT21039 an electronic tobacco vapor product

OTHER

Product C

FT21092 an electronic tobacco vapor product

OTHER

Product D

FT21018 an electronic tobacco vapor product

OTHER

Product E

4mg nicotine gum

Trial Locations (1)

68502

Celerion, Inc., Lincoln

Sponsors

Collaborators (1)

Celerion
All Listed Sponsors
collaborator

Celerion

INDUSTRY

lead

RAI Services Company

INDUSTRY

NCT03126357 - CSD170401: Study to Assess Elements of Abuse Liability for Three Electronic Tobacco Vapor Products During an 11-Day In-Clinic Confinement | Biotech Hunter | Biotech Hunter